Advances in Precision Medicine (APM)
Advances in Precision Medicine (APM) brings together all aspects of the rapidly growing field of personalized/precision medicine.Biomarkers are a key focus of APM’s scope. In particular, papers on stratification biomarkers and companion diagnostics enabling personalized medicine are highly welcome. Other categories of biomarkers accepted for consideration include pharmacodynamic biomarkers demonstrating target engagement which are potentially useful for dose finding, safety biomarkers to exclude patients with high risk for side effects or to detect induction of adverse effects early, and disease biomarkers which can be used for diagnosis, as surrogate endpoints, or to determine early response to therapy.
Aims & Scope
Advances in Precision Medicine (APM) brings together all aspects of the rapidly growing field of personalized/precision medicine.Biomarkers are a key focus of APM’s scope. In particular, papers on stratification biomarkers and companion diagnostics enabling personalized medicine are highly welcome. Other categories of biomarkers accepted for consideration include pharmacodynamic biomarkers demonstrating target engagement which are potentially useful for dose finding, safety biomarkers to exclude patients with high risk for side effects or to detect induction of adverse effects early, and disease biomarkers which can be used for diagnosis, as surrogate endpoints, or to determine early response to therapy.
Aims
- To provide a high-quality, peer-reviewed open-access platform for researchers, clinicians, and industry professionals to share innovative theories, practical methodologies, and empirical findings in the rapidly growing field of personalized and precision medicine.
- To facilitate the exchange of information and interdisciplinary collaboration among scholars, clinicians, and professionals worldwide, with a special focus on the development and validation of biomarkers for precision medicine.
- To bridge the significant gap between basic biomarker research and clinical/industrial practice, and promote the application of biomarker discoveries in real-world patient care, drug development, and personalized therapy scenarios.
- To encourage in-depth exploration and innovative research on emerging trends, hot issues, and practical challenges in precision medicine, particularly in the areas of stratification biomarkers, companion diagnostics, pharmacodynamic markers, safety biomarkers, and disease biomarkers.
Scope
The journal covers a wide range of topics related to personalized and precision medicine, including but not limited to:
Core Focus on Biomarkers in Precision Medicine
- Stratification biomarkers and companion diagnostics enabling personalized medicine
- Pharmacodynamic biomarkers demonstrating target engagement for dose finding and therapy optimization
- Safety biomarkers for identifying high-risk patients, early detection of adverse effects, and drug safety monitoring
- Disease biomarkers for diagnosis, use as surrogate endpoints, and early assessment of therapeutic response
- Biomarker discovery, validation, and translational research across all stages of drug development and clinical practice
Related Precision Medicine Domains
- Omics technologies (genomics, transcriptomics, proteomics, metabolomics) for biomarker identification
- Bioinformatics and statistical methods for biomarker data analysis and validation
- Clinical implementation of precision medicine strategies and personalized therapy approaches
- Regulatory, ethical, and practical considerations in the development and use of companion diagnostics and personalized medicine tools